National Centre for Asbestos-Related Diseases and School of Medicine and Pharmacology, The University of Western Australia, Perth, 6009 Western Australia, Australia.
Semin Immunopathol. 2011 Jul;33(4):353-67. doi: 10.1007/s00281-011-0246-z. Epub 2011 Jan 28.
The immune system plays an important role in the surveillance of neoplastic cells by eliminating them before they manifest as full-blown cancer. Despite this, tumors do develop in the presence of a functioning immune system. Conventional chemotherapy and its ability to directly kill tumor cells is one of the most effective weapons in the fight against cancer, however, increasing evidence suggests that the therapeutic efficacy of some cytotoxic drugs relies on their capacity to interact with the immune system. Killing of tumor cells in a manner that favors their capture by immune cells or selective targeting of immunosuppressive pathways by specific chemotherapies promotes the generation of an effective anti-cancer response; however, this alone is rarely sufficient to cause elimination of advanced disease. An understanding of the immunological events occurring in both animal models and patients undergoing chemotherapy will guide decisions for the development of appropriate combinations and scheduling for the integration of chemotherapy with immunotherapy.
免疫系统在监测肿瘤细胞方面起着重要作用,它可以在肿瘤完全形成之前将其消除。尽管如此,在免疫系统正常的情况下,肿瘤仍会发展。传统化疗及其直接杀死肿瘤细胞的能力是对抗癌症最有效的武器之一,然而,越来越多的证据表明,一些细胞毒性药物的治疗效果依赖于它们与免疫系统相互作用的能力。以有利于免疫细胞捕获肿瘤细胞的方式杀死肿瘤细胞,或者通过特定化疗有选择性地靶向免疫抑制途径,可促进有效的抗癌反应的产生;然而,仅靠这一点通常不足以消除晚期疾病。了解在接受化疗的动物模型和患者中发生的免疫学事件,将有助于做出决策,选择合适的联合用药,并安排化疗与免疫疗法的整合。